Clinical Trials Directory

Trials / Completed

CompletedNCT03375060

Histology Post-Endoscopic Eradication Therapy (EET)

Optimizing Patient Outcomes Through Early Detection of Uncontrolled Acid Reflux After Endoscopic Therapy in Barrett's Esophagus

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is looking at a cohort of patients who have undergone treatment for Barrett's Esophagus (BE) and who have experienced complete eradication of the disease. The aim of the proposed study is to evaluate the histologic features of the neosquamous epithelium (NSE) following complete eradication of intestinal metaplasia (CE-IM) in patients undergoing routine surveillance biopsies and compare these data to a direct measure of reflux using 24hr pH impedance, to determine the correlation between histology and persistent reflux. These data will allow us to more accurately risk stratify patients for recurrence of BE following EET.

Conditions

Timeline

Start date
2017-08-02
Primary completion
2017-11-05
Completion
2017-11-05
First posted
2017-12-15
Last updated
2017-12-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03375060. Inclusion in this directory is not an endorsement.

Histology Post-Endoscopic Eradication Therapy (EET) (NCT03375060) · Clinical Trials Directory